Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy
Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy
Not yet recruiting · NCT06470880 · Registry updated 2024-06-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Not yet recruiting | Phase 2 | 2024-06-24 | NCT06470880 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The Christie NHS Foundation Trust | 35 |
| University of Liverpool | 39 |
| University of Manchester | 85 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||